- Home
- BCML vs VRXA Comparison
BCML vs VRXA Comparison
Compare BCML & VRXA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BCML | VRXA |
|---|---|---|
| Founded | 2004 | N/A |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 364.8M | 390.3M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | BCML | VRXA |
|---|---|---|
| Price | $31.61 | $1.81 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $34.00 | N/A |
| AVG Volume (30 Days) | 50.1K | ★ 983.8K |
| Earning Date | 04-23-2026 | N/A |
| Dividend Yield | ★ 4.09% | N/A |
| EPS Growth | ★ 3.81 | N/A |
| EPS | ★ 0.75 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.71 | N/A |
| Revenue Next Year | $5.25 | N/A |
| P/E Ratio | $43.69 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $26.31 | $1.70 |
| 52 Week High | $34.98 | $4.50 |
Technical Indicators
Market Signals| Indicator | BCML | VRXA |
|---|---|---|
| Relative Strength Index (RSI) | 38.48 | 26.81 |
| Support Level | $31.34 | N/A |
| Resistance Level | $32.86 | $2.30 |
| Average True Range (ATR) | 0.79 | 0.34 |
| MACD | -0.26 | 0.02 |
| Stochastic Oscillator | 20.33 | 1.75 |
Price Performance
Historical ComparisonAbout BCML BayCom Corp
BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses, and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services. The Company operates as one reportable segment: banking operations.
About VRXA Veraxa Biotech AG Ordinary Shares
Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.